Spironolactone for resistant hypertension in advanced chronic kidney disease-red, amber or green? (2020)

First Author: Agarwal R

Attributed to: The Evaluation of blood pressure treatment stratified according to Central Aortic Systolic Pressure (CASP) in Young Hypertensive Patients - The TREAT CASP study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ndt/gfz299

PubMed Identifier: 32047939

Publication URI: http://europepmc.org/abstract/MED/32047939

Type: Journal Article/Review

Volume: 35

Parent Publication: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Issue: 8

ISSN: 0931-0509